Inovalon Announces Second Quarter 2021 Earnings Conference Call
July 14 2021 - 7:55AM
Inovalon (Nasdaq: INOV), a leading provider of cloud-based
platforms empowering data-driven healthcare, today announced that
it will hold a conference call for investors on Wednesday, July 28,
2021, at 5:00 p.m. Eastern Time. During the conference call,
management will review highlights from the Company’s second quarter
2021 financial results, which will be announced via press release
after the close of market trading.
The conference call can be accessed by dialing
(855) 783-2604, conference ID 4583925; international callers should
dial (631) 485-4882 using the same ID. The call will be available
for replay on Inovalon’s website at www.inovalon.com.
About Inovalon
Inovalon is a leading provider of cloud-based
platforms empowering data-driven healthcare. Through the Inovalon
ONE® Platform, Inovalon brings to the marketplace a national-scale
capability to interconnect with the healthcare ecosystem, aggregate
and analyze data in real time, and empower the application of
resulting insights to drive meaningful impact at the point of care.
Leveraging its Platform, unparalleled proprietary datasets, and
industry-leading subject matter expertise, Inovalon enables better
care, efficiency, and financial performance across the healthcare
ecosystem. From health plans and provider organizations, to
pharmaceutical, medical device, and diagnostics companies,
Inovalon’s unique achievement of value is delivered through the
effective progression of “Turning Data into Insight, and Insight
into Action®.” Supporting thousands of clients, including all 25 of
the top 25 U.S. health plans, all 25 of the top 25 global pharma
companies, 24 of the top 25 U.S. healthcare provider systems, and
many of the leading pharmacy organizations, device manufacturers,
and other healthcare industry constituents, Inovalon’s technology
platforms and analytics are informed by data pertaining to more
than one million physicians, 580,000 clinical facilities, 336
million Americans, and 62 billion medical events. For more
information, visit www.inovalon.com.
Contact:
Kim E. CollinsSenior Vice President, Corporate
Communications kcollins@inovalon.com 301-809-4000 x1473
Hulus AlpayVice President, Investor Relations
halpay@inovalon.com 301-809-4000 x1237
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Feb 2025 to Mar 2025
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Mar 2024 to Mar 2025